The BalancedInvestor Club

RVMDW Market Analysis

Overview

Fundamentals

P/E ratio—
EPS (TTM)—0.0% YoY
Profit margin0.0%
Market cap—

Valuation

Forward P/E
—
PEG ratio
—
P/B
—
P/S (TTM)
—
EV/EBITDA
—

Profitability & growth

ROE (TTM)
-76.7%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
—
Beta
1.41

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Revolution Medicines, Inc. Warrant

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops therapies to inhibit frontier targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
700 SAGINAW DRIVE, REDWOOD CITY, CA
Fiscal year end
December
Latest quarter
Mar 31, 2026
Shares outstanding$0
52W high$7.29
52W low$0.16

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer